Please see the paper attached below on evaluating the accuracy of Akonni Biosystems XDR-TB TruArray® and Lateral Flow Cell (XDR-LFC), a novel multiplex assay to simultaneously detect mutations across seven genes that confer resistance to both first and second-line anti-TB drugs.
Catanzaro_2020.pdf (1.0 MB)